Cancer Drug May Be Remedy For Rheumatoid Arthritis, Stanford University School of Medicine Study Finds

STANFORD, Calif.--(BUSINESS WIRE)--The potent cancer drug Gleevec, used to combat leukemia and some gastrointestinal cancers, may be useful in treating rheumatoid arthritis, according to a team of researchers at the Stanford University School of Medicine. Their findings will be published in the October issue of the Journal of Clinical Investigation.

Back to news